• Effectiveness of probiotics in combined therapy of atopic dermatitis

Effectiveness of probiotics in combined therapy of atopic dermatitis

SOVREMENNAYA PEDIATRIYA.2017.4(84):77-80; doi 10.15574/SP.2017.84.77

Nedelska S. M., Kuznietsova O. D., Shevchenko O. O., Kizilova I. A., Kolesnik O. Y.
Zaporozhye State Medical University, Ukraine
Communal Healthcare Institution Zaporizhzhya City Multidisciplinary Clinical Hospital No.5, Ukraine

Objective — to study of therapeutic efficacy of acute period of atopic dermatitis with inclusion of probiotic strain Lactobacillus rhamnosus GG (LGG® in microencapsulated form) into the complex treatment.

Materials and methods. A total of 36 children with moderate-to-severe atopic dermatitis (SCORAD more than 20 points) in the exacerbation phase were examened. All patients were divided into 2 groups: the main group consisted of 26 children (average age 8.6±1.3 years old) and were administrated Preema® in complex therapy, the comparison group comprised 10 children (aged 9.1±2.0 years) treated with standard remedies.

Results. After 2-week treatment in the main group SCORAD index reduced to 18.52±3.9 points, which was significantly lower than in the comparison group that made up 24.3±4.8 points (р<0.05). These differences continued to persist in a month follow-up examination (13.9±3.1 in the main group opposite 19.1±4.5 points in comparison group, р<0.05). Statistically significant reduction of skin itching in the 1st group patients was observed on the 7th and the 14th days of treatment. After 2-week therapy none of the main group patients complained of sleep disturbance as opposed to 20% of the comparison group patients (approximately 2 points according to the subjective scale, р<0.05).

Conclusion. Addition of Lactobacillus rhamnosus GG strain in microencapsulated form to the 3-4 week complex therapy of atopic dermatitis in children causes the statistically significant symptom reduction according to SCORAD index evaluation. Besides, it normalizes sleep disorders and eliminates the itching more quickly as compared to the standard therapy.

Key words: atopic dermatitis, children, probiotics, Preema®.


1. Kafarskaya LI, Shunikova ML, Efimov BA. (2011). Osobennosti formirovaniya mikrofloryi u detey rannego vozrasta i puti ee korrektsii s pomoschyu probiotikov. Pediatricheskaya farmakologiya. 8; 2: 94—98.

2. Makarova SG, Namazova-Baranova LS. (2015). Kishechnaya mikrobiota i ispolzovanie probiotikov v praktike pediatra. Chto novogo? Pediatricheskaya farmakologiya. 12(1): 38—45.

3. Berke R, Singh A, Guralnick M et al. (2012). Atopic Dermatitis: An Overview. Am Fam Physician. 86(1): 35—42. PMid:22962911

4. Schneider L, Tilles S, Lio P et al. (2013). Atopic dermatitis: A practice parameter update 2012. J Allergy Clin Immunol. 131: 295—299. https://doi.org/10.1016/j.jaci.2012.12.672; PMid:23374261

5. Esparza-Gordillo J, Dekio I. (2012). Atopic Dermatitis — Disease Etiology and Clinical Management. ISBN 978-953-51-0110-9, 414 pages: 326—350. https://doi.org/10.5772/1448

6. Brown K. (2012). Diet-Induced Dysbiosis of the Intestinal Microbiota and the Effects on Immunity and Disease. Nutrients. 4(8): 1095—1119. https://doi.org/10.3390/nu4081095; PMid:23016134 PMCid:PMC3448089

7. Yesilova Y et al. (2012). Effect of probiotics in the treatment of children with atopic dermatitis. Ann Dermatology. 24: 189—193. https://doi.org/10.5021/ad.2012.24.2.189; PMid:22577270 PMCid:PMC3346910

8. Abrahamsson TR et al. (2015). Gut microbiota and allergy: the importance of the pregnancy period. Pediatric Research. 77: 214—219. https://doi.org/10.1038/pr.2014.165; PMid:25310761

9. Abrahamsson TR et al. (2012). Low diversity of the gut microbiota in infants with atopic eczema. The Journal of Allergy and Clinical Immunology. 129(2): 434—440. https://doi.org/10.1016/j.jaci.2011.10.025; PMid:22153774

10. Pillar IN, Accioly E. (2013). Effect of the use of probiotics in the treatment of children with atopic dermatitis; a literature review. Nutr Hosp. 28(1): 16—26.

11. Gruber C, Wendt M, Sulser C et al. Randomized, placebo<controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy. Allergy. 62; Is 11: 1270—1276.